VanEck Bionic Engineering UCITS ETF A Acc

The VanEck Bionic Engineering UCITS ETF aims to provide investment returns that closely track the performance of the MVIS® Global Bionic Healthcare ESG Index. This exchange-traded fund invests in a portfolio of equity securities in the medical/dental or vision-related implants, bioprinting, or prosthesis sectors.

The fund is exposed to a global index that includes the largest and most liquid companies in the medical/dental or vision-related implants, bioprinting, or prosthesis sectors. The top holdings include companies such as Medtronic PLC, Stryker Corp, and Edwards Lifesciences Corp. The fund has a country breakdown with the United States, Switzerland, and Australia being the top countries represented.

Key risks associated with this fund include liquidity risk, equity market risk, and industry or sector concentration risk. Liquidity risk may arise if the market for a particular financial instrument is illiquid, impacting the ability to buy or sell at a reasonable price. Equity market risk exposes the fund to general economic conditions and potential drops in value. Industry or sector concentration risk means the fund's performance may be negatively impacted by adverse conditions in specific sectors or industries.

https://www.vaneck.com/de/de/bionik-etf/